×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Patients with pancreatic cancer face barriers to clinical trials as a standard of care.
Beth Fand Incollingo
Banishing sugar and extra body fat can be important tools in preventing cancer.
Kristie L. Kahl
The Food and Drug Administration granted a priority review to Tibsovo (ivosidenib) for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) with an IDH1 mutation who are not eligible for standard therapy.
More
Voices
Laura Yeager
At 56, after two bouts of cancer, I realized something about my life.
Jane Biehl PhD
I am thrilled to be enjoying a respite from chemo but afraid to be happy. How can I process this scary new freedom?
Barbara Tako
When and where to mention (or not mention) your ongoing cancer survivorship story?
More
CURE Connections®
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, provide their perspectives on adjusting to life with cancer of the head and neck, as a patient or as a caregiver, and share advice for those who must undergo laryngectomy.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, share insight into the role of novel treatment approaches like immunotherapy, robotic surgery and de-escalation in the management of cancers of the head and neck.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, review the various modalities of treatment for cancers of the head and neck and identify which physicians are responsible for delivering this care.
More
Videos
Mark Socinski, M.D.
Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.
Jean Diesch
Any action, larger or small, can make a major impact in the lives of patients with a myeloproliferative neoplasm.
Jarushka Naidoo, M.B.B.Ch.
Immunotherapy can cause some side effects that patients and practitioners should look out for.
More
Podcasts
Kristie L. Kahl
This week, we spoke with FORCE to dispel some of the misconceptions associated with at-home genetic testing for hereditary cancer risk.
Kristie L. Kahl
This week, we spoke with two faculty members from the patient-focused meeting at the upcoming Miami Breast Cancer Conference.
Brielle Benyon
Maria Falzone won't let her diagnosis of advanced cholangiocarcinoma stifle her sense of humor.
More
